Company Filing History:
2 out of 2 
1 out of 1 
1 out of 5 Years Active: 2022-2024
Title: Inventor Spotlight: Heejoon Myung
Introduction
Heejoon Myung is a renowned inventor based in Yongin-si, South Korea, known for his innovative contributions to the fields of biotechnology and antibiotics. With a portfolio that includes four patents, he has made significant strides in combating gram-negative bacterial infections and advancing bacteriophage technology.
Latest Patents
Heejoon Myung's latest patents demonstrate his commitment to addressing critical health issues. One noteworthy patent is focused on a novel polypeptide exhibiting endolysin activity, along with a fusion protein that includes an antibiotic active protein. This invention adds valuable tools for the prevention and treatment of infections caused by gram-negative pathogens. Another significant patent outlines a method and composition for enhancing the production of bacteriophages using reactive oxygen species (ROS). This innovative approach allows for a substantial increase in bacteriophage yield, offering a potential alternative to traditional antibiotics amid rising resistance issues.
Career Highlights
Throughout his career, Heejoon Myung has held positions at notable companies, including Lysentech Co., Ltd. and Lysentech. His expertise in biotechnology and antibiotic development has positioned him as a leader in the field, contributing to groundbreaking research efforts.
Collaborations
Heejoon Myung has collaborated with esteemed colleagues, including Min Soo Kim and Jaeyeon Jang. Their collective efforts have enhanced research initiatives and contributed to advancements in their respective areas of specialization.
Conclusion
In summary, Heejoon Myung exemplifies the spirit of innovation through his patents and collaborative work. His contributions to the fields of antibiotic development and bacteriophage technology are paving the way for new solutions to complex health challenges. As an inventor, his ongoing research promises to make a lasting impact in combating bacterial infections and improving healthcare outcomes.